The Diagnostic Assessment of Canine Lymphoma: Implications for Treatment

Dorothee Bienzle, William Vernau

Research output: Contribution to journalArticlepeer-review

26 Scopus citations


Lymphoma in dogs is a heterogeneous cancer with highly variable prognosis. Many types of canine lymphoma have similar counterparts in the World Health Organization classification of human lymphoid tumors. The most common variant of canine lymphoma is diffuse large B-cell lymphoma, which, if treated with multiagent chemotherapy, has a survival time of approximately 12 months. T-cell lymphomas are more heterogeneous and high- and low-grade variants are common, which necessitates classification beyond B- versus T-cell lineage.

Original languageEnglish (US)
Pages (from-to)21-39
Number of pages19
JournalClinics in Laboratory Medicine
Issue number1
StatePublished - Mar 2011


  • Clonal antigen receptor polymerase chain reaction
  • Flow cytometry
  • Immunohistochemistry
  • Lymphosarcoma
  • Veterinary
  • WHO classification

ASJC Scopus subject areas

  • Biochemistry, medical
  • Clinical Biochemistry


Dive into the research topics of 'The Diagnostic Assessment of Canine Lymphoma: Implications for Treatment'. Together they form a unique fingerprint.

Cite this